87 related articles for article (PubMed ID: 21993313)
1. Regulation of the hematopoietic cell kinase (HCK) by PML/RARα and PU.1 in acute promyelocytic leukemia.
Zou D; Yang X; Tan Y; Wang P; Zhu X; Yang W; Jia X; Zhang J; Wang K
Leuk Res; 2012 Feb; 36(2):219-23. PubMed ID: 21993313
[TBL] [Abstract][Full Text] [Related]
2. Direct interaction of PU.1 with oncogenic transcription factors reduces its serine phosphorylation and promoter binding.
Seshire A; Rößiger T; Frech M; Beez S; Hagemeyer H; Puccetti E
Leukemia; 2012 Jun; 26(6):1338-47. PubMed ID: 22105598
[TBL] [Abstract][Full Text] [Related]
3. C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukemia.
Riccioni R; Saulle E; Militi S; Sposi NM; Gualtiero M; Mauro N; Mancini M; Diverio D; Lo Coco F; Peschle C; Testa U
Leukemia; 2003 Jan; 17(1):98-113. PubMed ID: 12529666
[TBL] [Abstract][Full Text] [Related]
4. A new molecular network comprising PU.1, interferon regulatory factor proteins and miR-342 stimulates ATRA-mediated granulocytic differentiation of acute promyelocytic leukemia cells.
De Marchis ML; Ballarino M; Salvatori B; Puzzolo MC; Bozzoni I; Fatica A
Leukemia; 2009 May; 23(5):856-62. PubMed ID: 19151778
[TBL] [Abstract][Full Text] [Related]
5. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.
Rusiniak ME; Yu M; Ross DT; Tolhurst EC; Slack JL
Cancer Res; 2000 Apr; 60(7):1824-9. PubMed ID: 10766166
[TBL] [Abstract][Full Text] [Related]
6. Coordinated regulation of the immunoproteasome subunits by PML/RARα and PU.1 in acute promyelocytic leukemia.
Yang XW; Wang P; Liu JQ; Zhang H; Xi WD; Jia XH; Wang KK
Oncogene; 2014 May; 33(21):2700-8. PubMed ID: 23770850
[TBL] [Abstract][Full Text] [Related]
7. The significance of low PU.1 expression in patients with acute promyelocytic leukemia.
Zhu X; Zhang H; Qian M; Zhao X; Yang W; Wang P; Zhang J; Wang K
J Hematol Oncol; 2012 May; 5():22. PubMed ID: 22569057
[TBL] [Abstract][Full Text] [Related]
8. PML/RARalpha targets promoter regions containing PU.1 consensus and RARE half sites in acute promyelocytic leukemia.
Wang K; Wang P; Shi J; Zhu X; He M; Jia X; Yang X; Qiu F; Jin W; Qian M; Fang H; Mi J; Yang X; Xiao H; Minden M; Du Y; Chen Z; Zhang J
Cancer Cell; 2010 Feb; 17(2):186-97. PubMed ID: 20159610
[TBL] [Abstract][Full Text] [Related]
9. A network including PU.1, Vav1 and miR-142-3p sustains ATRA-induced differentiation of acute promyelocytic leukemia cells - a short report.
Grassilli S; Nika E; Lambertini E; Brugnoli F; Piva R; Capitani S; Bertagnolo V
Cell Oncol (Dordr); 2016 Oct; 39(5):483-489. PubMed ID: 27480083
[TBL] [Abstract][Full Text] [Related]
10. A novel PAD4/SOX4/PU.1 signaling pathway is involved in the committed differentiation of acute promyelocytic leukemia cells into granulocytic cells.
Song G; Shi L; Guo Y; Yu L; Wang L; Zhang X; Li L; Han Y; Ren X; Guo Q; Bi K; Jiang G
Oncotarget; 2016 Jan; 7(3):3144-57. PubMed ID: 26673819
[TBL] [Abstract][Full Text] [Related]
11. C/EBPα and PU.1 are involved in distinct differentiation responses of acute promyelocytic leukemia HL-60 and NB4 cells via chromatin remodeling.
Savickiene J; Treigyte G; Vistartaite G; Tunaitis V; Magnusson KE; Navakauskiene R
Differentiation; 2011 Jan; 81(1):57-67. PubMed ID: 20864248
[TBL] [Abstract][Full Text] [Related]
12. PU.1 can regulate the ZNF300 promoter in APL-derived promyelocytes HL-60.
Xu JH; Wang T; Wang XG; Wu XP; Zhao ZZ; Zhu CG; Qiu HL; Xue L; Shao HJ; Guo MX; Li WX
Leuk Res; 2010 Dec; 34(12):1636-46. PubMed ID: 20471086
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells.
Yan H; Peng ZG; Wu YL; Jiang Y; Yu Y; Huang Y; Zhu YS; Zhao Q; Chen GQ
Haematologica; 2005 Dec; 90(12):1607-16. PubMed ID: 16330433
[TBL] [Abstract][Full Text] [Related]
14. PU.1 is linking the glycolytic enzyme HK3 in neutrophil differentiation and survival of APL cells.
Federzoni EA; Valk PJ; Torbett BE; Haferlach T; Löwenberg B; Fey MF; Tschan MP
Blood; 2012 May; 119(21):4963-70. PubMed ID: 22498738
[TBL] [Abstract][Full Text] [Related]
15. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
Marasca R; Zucchini P; Galimberti S; Leonardi G; Vaccari P; Donelli A; Luppi M; Petrini M; Torelli G
Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155
[TBL] [Abstract][Full Text] [Related]
16. Repression of CDKN2C caused by PML/RARα binding promotes the proliferation and differentiation block in acute promyelocytic leukemia.
Wang X; Tan Y; Li Y; Li J; Jin W; Wang K
Front Med; 2016 Dec; 10(4):420-429. PubMed ID: 27888400
[TBL] [Abstract][Full Text] [Related]
17. Blockade of the ubiquitin protease UBP43 destabilizes transcription factor PML/RARα and inhibits the growth of acute promyelocytic leukemia.
Guo Y; Dolinko AV; Chinyengetere F; Stanton B; Bomberger JM; Demidenko E; Zhou DC; Gallagher R; Ma T; Galimberti F; Liu X; Sekula D; Freemantle S; Dmitrovsky E
Cancer Res; 2010 Dec; 70(23):9875-85. PubMed ID: 20935222
[TBL] [Abstract][Full Text] [Related]
18. Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation.
Nasr R; Guillemin MC; Ferhi O; Soilihi H; Peres L; Berthier C; Rousselot P; Robledo-Sarmiento M; Lallemand-Breitenbach V; Gourmel B; Vitoux D; Pandolfi PP; Rochette-Egly C; Zhu J; de Thé H
Nat Med; 2008 Dec; 14(12):1333-42. PubMed ID: 19029980
[TBL] [Abstract][Full Text] [Related]
19. PML/RARalpha, a fusion protein in acute promyelocytic leukemia, prevents growth factor withdrawal-induced apoptosis in TF-1 cells.
Fu S; Consoli U; Hanania EG; Zu Z; Claxton DF; Andreeff M; Deisseroth AB
Clin Cancer Res; 1995 Jun; 1(6):583-90. PubMed ID: 9816019
[TBL] [Abstract][Full Text] [Related]
20. Detecting PML-RARalpha transcript in acute promyelocytic leukemia using real-time quantitative RT-PCR.
Zhu HH; Liu YR; Qin YZ; Jiang B; Shan FX; Wu SL; Yang PD; Zhao J; Lu DP
Chin Med J (Engl); 2007 Oct; 120(20):1803-8. PubMed ID: 18028775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
